Maud Reymond

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study

Anthony Buisson, Maria Nachury, Maud Reymond et al. · Clinical Gastroenterology and Hepatology · 2022 · 88 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn’s disease

Pierre Lafeuille, Constance Hordonneau, Jeanne Vignette et al. · Alimentary Pharmacology & Therapeutics · 2020 · 86 citations · Full text

Medicine, Radiology, Surgery +16

Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn’s disease

Anthony Buisson, Marion Goutte, Maud Reymond et al. · Digestive and Liver Disease · 2017 · 62 citations

Medicine, Clinical Sciences, Radiology +16

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study

Bénédicte Caron, Laurent Peyrin‐Biroulet, Benjamin Pariente et al. · Journal of Crohn s and Colitis · 2019 · 57 citations · Full text

Medicine, Pharmacotherapy, Hepatic Pharmacotherapy +14

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

Gilles Bommelaer, David Laharie, Stéphane Nancey et al. · Clinical Gastroenterology and Hepatology · 2019 · 56 citations

Medicine, Surgery, Gastroenterology +4